Valcare touts 1st-in-human use of Amend annulplasty ring

Valcare touts 1st-in-human use of Amend annulplasty ring

Israeli heart valve device developer Valcare Medical today announced the 1st implantations of its Amend mitral valve repair annuloplasty ring, completing the 1st phase of its 1st-in-human multi-center clinical trial evaluating the device.

Read more


Valcare completes first phase of first-in-human Amend trial

Valcare completes first phase of first-in-human Amend trial

Valcare developed the Amend mitral valve repair annuloplasty ring—a semi-rigid, a ’D’ shaped ring designed to emulate the current gold standard for patients who suffer from mitral valve regurgitation. In a series of cases, the ring was successfully trans apically delivered through a catheter-based delivery system, and was secured to the annulus by a series of novel integral anchors.

Read more